FIELD: pharmaceuticals.
SUBSTANCE: invention generally relates to inhibitors of the mycobacterial membrane protein MmpL3, compositions containing these inhibitors, and methods for their preparation and use. The invention relates to new inhibitors of the mycobacteria MmpL3 membrane protein of formula I.
EFFECT: obtaining new compounds being the inhibitors of the mycobacteria MmpL3 membrane protein that can be used in a method for treating mycobacterial infection.
12 cl, 2 tbl, 35 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2,5-DISUBSTITUTED ARYLSULPHONAMIDE CCR3 ANTAGONISTS | 2010 |
|
RU2532515C2 |
| (ALPHA-SUBSTITUTED ARALKYLAMINO- AND HETEROARYLALKYLAMINO)PYRIMIDINYL- AND 1,3,5-TRIAZINYLBENZIMIDAZOLES, PHARMACEUTICAL COMPOSITIONS THEREOF AND USE THEREOF IN TREATING PROLIFERATIVE DISEASES | 2012 |
|
RU2608742C2 |
| GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 |
|
RU2805308C2 |
| ARYLSULPHONAMIDE CCR3 ANTAGONISTS | 2010 |
|
RU2539591C2 |
| DIAZAHOMOADAMANTANE DERIVATIVES AND METHODS OF USING THEM | 2010 |
|
RU2549551C2 |
| STEROIDS THAT RELEASE NITROGEN OXIDE | 2008 |
|
RU2442790C2 |
| DUAL-ACTING ANTIHYPERTENSIVE COMPOUNDS, METHODS FOR PREPARING THEM, BASED PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE COMPOUNDS | 2008 |
|
RU2476427C2 |
| ION CHANNEL INHIBITORS, PHARMACEUTICAL FORMULATIONS AND APPLICATIONS | 2016 |
|
RU2746188C2 |
| PROCESSES FOR MAKING COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | 2012 |
|
RU2677292C2 |
| CLASS OF CONDENSED RING COMPOUNDS AND THEIR PRODUCTION AND USE | 2021 |
|
RU2831125C1 |
